Exodus Point Capital Management, LP Sutro Biopharma, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.78 - $15.31 $373,541 - $735,079	-48,013 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$14.25 - $23.53 $324,244 - $535,401	22,754 Added 90.08%	48,013 $714,000
Q3 2021 Nov 15, 2021	BUY	$16.88 - $22.38 $426,371 - $565,296	25,259 New	25,259 $477,000
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $837,908 - $1.11 Million	-46,473 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $205,436 - $278,842	10,125 Added 27.86%	46,473 $1.06 Million

Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $369,295 - $871,625	36,348 New	36,348 $789,000

122

53.3M

7.8K

2.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $152M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.